• Title of article

    Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase

  • Author/Authors

    Jeffrey Y. Melamed، نويسنده , , Melissa S. Egbertson، نويسنده , , Sandor Varga، نويسنده , , Joseph P. Vacca، نويسنده , , Greg Moyer، نويسنده , , Lori Gabryelski، نويسنده , , Peter J. Felock، نويسنده , , Kara A. Stillmock، نويسنده , , Marc V. Witmer، نويسنده , , William Schleif، نويسنده , , Daria J. Hazuda، نويسنده , , Yvonne Leonard، نويسنده , , Lixia Jin، نويسنده , , Joan D. Ellis، نويسنده , , Steven D. Young، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2008
  • Pages
    4
  • From page
    5307
  • To page
    5310
  • Abstract
    HIV-1 integrase catalyzes the insertion of viral DNA into the genome of the host cell. Integrase inhibitor N-(4-fluorobenzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamide selectively inhibits the strand transfer process of integration. 4-Substituted pyrrolidinones possessing various groups on the pyrrolidinone nitrogen were introduced at the 5-position of the naphthyridine scaffold. These analogs exhibit excellent activity against viral replication in a cell-based assay. The preparation of these compounds was enabled by a three-step, two-pot reaction sequence from a common butenolide intermediate.
  • Keywords
    integrase , antiviral , Pyrrolidinone synthesis , 1 , 6-Naphthyridine , HIV , butenolide
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Serial Year
    2008
  • Journal title
    Bioorganic & Medicinal Chemistry Letters
  • Record number

    800005